Spotlight
Clinical
Video Series
News
Publication
CME/CE
Partners
Emerging Treatment Options for C. Difficile Infections
Healthcare experts comment on current data associated with emerging microbiota therapies that are currently under study for the treatment of C. difficile infections.
EP: 1.C. Difficile Risk Factors and Manifestation
EP: 2.Strains of C. Difficile
EP: 3.Managing Community-Onset C. Difficile
EP: 4.Recurrent C. Difficile
EP: 5.C. Difficile: A Differential Diagnosis
EP: 6.Testing for C. Difficile Infections
EP: 7.Screening for C. Difficile
EP: 8.C. Difficile: Clinical Practice Guidelines and Treatment Options
EP: 9.C. Difficile: Updates to Clinical Practice Guidelines
EP: 10.Selecting Therapy to Treat C. Difficile
EP: 11.C. Difficile Treatment: Fidaxomicin
EP: 12.Choosing Between Vancomycin and Fidaxomicin for C. Difficile Infections
EP: 13.C. Difficile Treatment: Bezlotoxumab
EP: 14.Preventing/Treating C. Difficile: Unmet Needs
EP: 15.Fecal Microbiota Transplantation for C. Difficile Infections
Now Viewing
EP: 16.Emerging Treatment Options for C. Difficile Infections
EP: 17.C. Difficile: Barriers Treating With FMT
EP: 18.Making Strides in the Management of C. Difficile
Related Videos
Related Content
